MGX Stock Analysis: Buy, Sell, or Hold?
MGX - Metagenomi, Inc. Common Stock
$1.25
0.06 (5.04%)
▲
5d:
+4.17%
30d:
-7.41%
90d:
-10.07%
BUY
HIGH Confidence
Analysis Updated: Jun 26, 2026 12:00 AM ET
Earnings: Aug 11, 2026
Get Alerted When MGX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: MGX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: MGX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: MGX is currently trading at $1.25, which is considered fair relative to its 30-day fair value range of $1.20 to $1.33.
Technical Outlook: Technically, MGX is in a strong downtrend. Immediate support is located at $1.21, while resistance sits at $1.42. The stock is showing strong short-term momentum, up 5.0% recently.
Market Sentiment: MGX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.00 (+540.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MGX is in a strong downtrend. Immediate support is located at $1.21, while resistance sits at $1.42. The stock is showing strong short-term momentum, up 5.0% recently.
Market Sentiment: MGX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.00 (+540.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.20 -
$1.33
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
92.1%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.0%)
- BULLISH: Trading 540.0% below Wall St target ($8.00)
Trading Range Analysis
30-Day Trading Range
$1.20 -
$1.33
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.21
Resistance Level
$1.42
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.68
Wall Street Target
$8.00
(+540.0%)
Revenue Growth (YoY)
-69.8%
Share & Embed Analysis
Last updated: June 26, 2026 7:05 PM ET
Data refreshes hourly during market hours. Next update: 8:05 PM
Data refreshes hourly during market hours. Next update: 8:05 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MGX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Pamela Wapnick
SELL
1581 shares
2026-03-05
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 58 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 53 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 59 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 54 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
